1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Nuclear Imaging Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Nuclear Imaging Device Market Analysis and Forecasts, 2017 – 2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Regulatory Scenario
5.2. Technological Advancements
5.3. Key Industry Events
5.4. COVID-19 Pandemic Impact on Industry
6. Global Nuclear Imaging Devices Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017 – 2031
6.3.1. PET Devices
6.3.1.1. Standalone PET
6.3.1.2. PET/CT
6.3.1.3. PET/MRI
6.3.2. SPECT Devices
6.3.2.1. Standalone SPECT
6.3.2.2. SPECT/CT
6.3.2.3. SPECT/MRI
6.3.3. Planar Imaging Devices
6.4. Market Attractiveness Analysis, by Product Type
7. Global Nuclear Imaging Devices Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017 – 2031
7.3.1. Oncology
7.3.2. Cardiology
7.3.3. Neurology
7.3.4. Others (Nephrology, Immunology, etc.)
7.4. Market Attractiveness Analysis, by Application
8. Global Nuclear Imaging Devices Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017 – 2031
8.3.1. Hospitals
8.3.2. Imaging Centers
8.3.3. Academic and Research Centers
8.3.4. Others (Clinics, CROs, etc.)
8.4. Market Attractiveness Analysis, by End-user
9. Global Nuclear Imaging Devices Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017 – 2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Nuclear Imaging Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017 – 2031
10.2.1. PET Devices
10.2.1.1. Standalone PET
10.2.1.2. PET/CT
10.2.1.3. PET/MRI
10.2.2. SPECT Devices
10.2.2.1. Standalone SPECT
10.2.2.2. SPECT/CT
10.2.2.3. SPECT/MRI
10.2.3. Planar Imaging Devices
10.3. Market Value Forecast, by Application, 2017 – 2031
10.3.1. Oncology
10.3.2. Cardiology
10.3.3. Neurology
10.3.4. Others (Nephrology, Immunology, etc.)
10.4. Market Value Forecast, by End-user, 2017 – 2031
10.4.1. Hospitals
10.4.2. Imaging Centers
10.4.3. Academic and Research Centers
10.4.4. Others (Clinics, CROs, etc.)
10.5. Market Value Forecast, by Country, 2017 – 2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Nuclear Imaging Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017 – 2031
11.2.1. PET Devices
11.2.1.1. Standalone PET
11.2.1.2. PET/CT
11.2.1.3. PET/MRI
11.2.2. SPECT Devices
11.2.2.1. Standalone SPECT
11.2.2.2. SPECT/CT
11.2.2.3. SPECT/MRI
11.2.3. Planar Imaging Devices
11.3. Market Value Forecast, by Application, 2017 – 2031
11.3.1. Oncology
11.3.2. Cardiology
11.3.3. Neurology
11.3.4. Others (Nephrology, Immunology, etc.)
11.4. Market Value Forecast, by End-user, 2017 – 2031
11.4.1. Hospitals
11.4.2. Imaging Centers
11.4.3. Academic and Research Centers
11.4.4. Others (Clinics, CROs, etc.)
11.5. Market Value Forecast, by Country/Sub-region, 2017 – 2031
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Nuclear Imaging Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017 – 2031
12.2.1. PET Devices
12.2.1.1. Standalone PET
12.2.1.2. PET/CT
12.2.1.3. PET/MRI
12.2.2. SPECT Devices
12.2.2.1. Standalone SPECT
12.2.2.2. SPECT/CT
12.2.2.3. SPECT/MRI
12.2.3. Planar Imaging Devices
12.3. Market Value Forecast, by Application, 2017 – 2031
12.3.1. Oncology
12.3.2. Cardiology
12.3.3. Neurology
12.3.4. Others (Nephrology, Immunology, etc.)
12.4. Market Value Forecast, by End-user, 2017 – 2031
12.4.1. Hospitals
12.4.2. Imaging Centers
12.4.3. Academic and Research Centers
12.4.4. Others (Clinics, CROs, etc.)
12.5. Market Value Forecast, by Country/Sub-region, 2017 – 2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Nuclear Imaging Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017 – 2031
13.2.1. PET Devices
13.2.1.1. Standalone PET
13.2.1.2. PET/CT
13.2.1.3. PET/MRI
13.2.2. SPECT Devices
13.2.2.1. Standalone SPECT
13.2.2.2. SPECT/CT
13.2.2.3. SPECT/MRI
13.2.3. Planar Imaging Devices
13.3. Market Value Forecast, by Application, 2017 – 2031
13.3.1. Oncology
13.3.2. Cardiology
13.3.3. Neurology
13.3.4. Others (Nephrology, Immunology, etc.)
13.4. Market Value Forecast, by End-user, 2017 – 2031
13.4.1. Hospitals
13.4.2. Imaging Centers
13.4.3. Academic and Research Centers
13.4.4. Others (Clinics, CROs, etc.)
13.5. Market Value Forecast, by Country/Sub-region, 2017 – 2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Nuclear Imaging Devices Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017 – 2031
14.2.1. PET Devices
14.2.1.1. Standalone PET
14.2.1.2. PET/CT
14.2.1.3. PET/MRI
14.2.2. SPECT Devices
14.2.2.1. Standalone SPECT
14.2.2.2. SPECT/CT
14.2.2.3. SPECT/MRI
14.2.3. Planar Imaging Devices
14.3. Market Value Forecast, by Application, 2017 – 2031
14.3.1. Oncology
14.3.2. Cardiology
14.3.3. Neurology
14.3.4. Others (Nephrology, Immunology, etc.)
14.4. Market Value Forecast, by End-user, 2017 – 2031
14.4.1. Hospitals
14.4.2. Imaging Centers
14.4.3. Academic and Research Centers
14.4.4. Others (Clinics, CROs, etc.)
14.5. Market Value Forecast, by Country/Sub-region, 2017 – 2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. Koninklijke Philips N.V.
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. Business Strategies
15.3.1.5. Recent Developments
15.3.2. GE Healthcare
15.3.2.1. Company Overview
15.3.2.2. Financial Overview
15.3.2.3. Product Portfolio
15.3.2.4. Business Strategies
15.3.2.5. Recent Developments
15.3.3. Canon Medical Systems Corporation
15.3.3.1. Company Overview
15.3.3.2. Financial Overview
15.3.3.3. Product Portfolio
15.3.3.4. Business Strategies
15.3.3.5. Recent Developments
15.3.4. Siemens Healthineers AG
15.3.4.1. Company Overview
15.3.4.2. Financial Overview
15.3.4.3. Product Portfolio
15.3.4.4. Business Strategies
15.3.4.5. Recent Developments
15.3.5. Shimadzu Corporation
15.3.5.1. Company Overview
15.3.5.2. Financial Overview
15.3.5.3. Product Portfolio
15.3.5.4. Business Strategies
15.3.5.5. Recent Developments
15.3.6. MR Solutions
15.3.6.1. Company Overview
15.3.6.2. Financial Overview
15.3.6.3. Product Portfolio
15.3.6.4. Business Strategies
15.3.6.5. Recent Developments
15.3.7. Neusoft Medical Systems Co., Ltd.
15.3.7.1. Company Overview
15.3.7.2. Financial Overview
15.3.7.3. Product Portfolio
15.3.7.4. Business Strategies
15.3.7.5. Recent Developments
15.3.8. Mediso Ltd.
15.3.8.1. Company Overview
15.3.8.2. Financial Overview
15.3.8.3. Product Portfolio
15.3.8.4. Business Strategies
15.3.8.5. Recent Developments
15.3.9. MiE GmbH
15.3.9.1. Company Overview
15.3.9.2. Financial Overview
15.3.9.3. Product Portfolio
15.3.9.4. Business Strategies
15.3.9.5. Recent Developments
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer